M WINKWORTH PLC
WINK | IL
Overview
Corporate Details
- ISIN(s):
- GB00B4TT7L53
- LEI:
- 213800W7G6NJ2PRNUM27
- Country:
- United Kingdom
- Address:
- 13 CHARLES II STREET, ST. JAMES'S, SW1Y 4QU LONDON
- Website:
- N/A
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
N4 Pharma PLC develops and licenses Nuvec¨, a novel silica nanoparticle drug delivery system enhancing vaccines & therapeutics. Established 2014, the company focuses on improving nucleic acid delivery for gene therapy, cancer treatment, and vaccines.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-02-07 08:00 |
Regulatory News Service
Lawrence Alkin
|
English | 10.9 KB | |
| 2025-01-31 08:00 |
Regulatory News Service
Change of Registered Office
|
English | 8.9 KB | |
| 2025-01-15 08:00 |
Earnings Release
Trading Update and Dividend Declaration
|
English | 12.5 KB | |
| 2024-10-14 18:15 |
Board/Management Change
Appointment of Company Secretary
|
English | 7.5 KB | |
| 2024-10-09 08:00 |
Notice of Dividend Amount
Dividend Declaration
|
English | 10.1 KB | |
| 2024-09-26 16:20 |
Transaction in Own Shares
Director/PDMR Shareholding
|
English | 17.7 KB | |
| 2024-09-11 08:00 |
Earnings Release
Half-year Report
|
English | 336.6 KB | |
| 2024-08-30 08:00 |
Report Publication Announcement
Notice of Results and Investor Presentation
|
English | 8.0 KB | |
| 2024-07-10 08:00 |
Earnings Release
Dividend Announcement and Trading Update
|
English | 11.6 KB | |
| 2024-06-05 08:00 |
Board/Management Change
Directorate Change
|
English | 13.8 KB | |
| 2024-05-28 16:54 |
Declaration of Voting Results & Voting Rights Announcements
Result of AGM
|
English | 7.1 KB | |
| 2024-04-17 08:00 |
Earnings Release
Final Results
|
English | 213.9 KB | |
| 2024-04-10 08:00 |
Notice of Dividend Amount
Dividend Declaration
|
English | 10.4 KB | |
| 2024-04-03 08:00 |
Report Publication Announcement
Notice of Results and Investor Presentation
|
English | 11.0 KB | |
| 2024-02-13 08:00 |
Board/Management Change
Directorate Change
|
English | 11.4 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
Toleranzia AB | Sweden | TOL | |
|
Transgene | France | TNG | |
|
Tvardi Therapeutics Inc. | United States of America | TVRD | |
|
Ulisse Biomed | Italy | UBM | |
|
Univo Pharmaceuticals Ltd. | Israel | UNVO-M | |
|
Urteste S.A. | Poland | URT | |
|
Valbiotis | France | ALVAL | |
|
VALIRX PLC | United Kingdom | VAL | |
|
Vaxxa AB | Sweden | VAXXA | |
| Vision Sigma Ltd. | Israel | VISN |